---
title: Biomarkers
date: '2025-01-09'
linkTitle: https://pubmed.ncbi.nlm.nih.gov/39786105/?utm_source=curl&utm_medium=rss&utm_campaign=pubmed-2&utm_content=1FakS-2QOkCT8HsMOQP1bCRQ4YzyumYOmxmF0moLsQ3dFB1E9V&fc=20220326224207&ff=20250109170938&v=2.18.0.post9+e462414
source: heidelberg[Affiliation]
description: 'CONCLUSION: Longitudinal ^(18)F-MK6240 is a robust tool for estimating
  natural progression of tau accumulation. Our findings indicate that it typically
  takes around 15 years to reach the tau levels associated with mild AD once tau starts
  aggregating in the neocortex. These findings shed light into the initial stages
  of cortical tau accumulation, relevant for early diagnosis and therapeutic interventions
  in ...'
disable_comments: true
---
CONCLUSION: Longitudinal ^(18)F-MK6240 is a robust tool for estimating natural progression of tau accumulation. Our findings indicate that it typically takes around 15 years to reach the tau levels associated with mild AD once tau starts aggregating in the neocortex. These findings shed light into the initial stages of cortical tau accumulation, relevant for early diagnosis and therapeutic interventions in ...